You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Talazoparib

Showing 1 - 25 of 107
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial (ADT, Enzalutamide, Talazoparib)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
May 15, 2023

Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)

Active, not recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +1 more
Oct 10, 2022

Metastatic Castration-Resistant Prostate Cancer Trial (Talazoparib)

Available
  • Metastatic Castration-Resistant Prostate Cancer
  • Talazoparib
  • (no location specified)
Dec 6, 2022

Breast Cancer, Advanced Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Not yet recruiting
  • Breast Cancer
  • Advanced Breast Cancer
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University
Nov 9, 2022

Breast Cancer Trial in Boston (Talazoparib, Sacituzumab Govitecan)

Recruiting
  • Breast Cancer
  • Talazoparib
  • Sacituzumab Govitecan
  • Boston, Massachusetts
  • +1 more
Jan 6, 2023

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Baltimore, Buffalo (Gemtuzumab Ozogamicin,

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Gemtuzumab Ozogamicin
  • +4 more
  • Baltimore, Maryland
  • +1 more
Dec 13, 2022

Advanced Solid Tumor, Metastatic Solid Tumor Trial (ART6043, Olaparib, Talazoparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Jun 1, 2023

BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

Active, not recruiting
  • BRCA1 Mutation
  • +4 more
  • Talazoparib Oral Capsule
  • Providence, Rhode Island
  • +1 more
Nov 30, 2022

Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial (Pidnarulex, Talazoparib)

Not yet recruiting
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jun 15, 2022

Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)

Recruiting
  • Metastatic Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Jul 18, 2022

Metastatic Prostate Cancer Trial in Spain (Enzalutamide, Talazoparib)

Recruiting
  • Metastatic Prostate Cancer
  • Badalona, Spain
  • +8 more
Jan 18, 2023

Among Talazoparib-Treated HER2-Negative mBC With gBRCA1/2m

Completed
  • Metastatic Breast Cancer
  • Breast Neoplasms
  • Talazoparib
  • New York, New York
    Pfizer Inc.
Aug 5, 2022

Acute Myeloid Leukemia Trial in Stanford (Talazoparib, Topotecan, Gemcitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Talazoparib
  • +2 more
  • Stanford, California
    Stanford University
Jun 10, 2022

Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Active, not recruiting
  • Advanced Breast Cancer
  • +2 more
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University Hospitals and Clinics
Nov 16, 2022

Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jan 3, 2023

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Pittsburgh (ZEN003694, Talazoparib)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Apr 27, 2022

Lung Cancer, Small-Cell Lung Cancer Trial in Toronto (Talazoparib in Combination with Low Dose Radiotherapy (RT))

Recruiting
  • Lung Cancer
  • Small-Cell Lung Cancer
  • Talazoparib in Combination with Low Dose Radiotherapy (RT)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Center, University Health Network
Feb 25, 2022

Urothelial Carcinoma Trial in France (Talazoparib + Avelumab)

Recruiting
  • Urothelial Carcinoma
  • Talazoparib + Avelumab
  • Angers, France
  • +13 more
Aug 9, 2022

Recurrent Extensive Stage Small Cell Lung Carcinoma, Refractory Extensive Stage Small Cell Lung Carcinoma Trial in United States

Active, not recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Refractory Extensive Stage Small Cell Lung Carcinoma
  • Bakersfield, California
  • +5 more
Jan 5, 2023

Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +7 more
  • BET Bromodomain Inhibitor ZEN-3694
  • Talazoparib
  • Atlanta, Georgia
  • +2 more
Nov 3, 2022

Metastatic or Unresectable Melanoma Trial in Cleveland (Nivolumab, Talazoparib)

Recruiting
  • Metastatic or Unresectable Melanoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Mar 22, 2022

Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Ovarian Carcinoma Trial in Ann Arbor

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Mar 31, 2022

Kidney Cancer, Renal Cell Carcinoma, Unresectable Renal Cell Carcinoma Trial in United States (Talazoparib, Axitinib)

Recruiting
  • Kidney Cancer
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 8, 2022

Advanced or Recurrent Solid Tumors, Breast Tumor Trial in Tirana, Zürich (Injections Subcutaneously Talazoparib, Oral capsules

Not yet recruiting
  • Advanced or Recurrent Solid Tumors
  • Breast Neoplasm
  • Injections Subcutaneously Talazoparib
  • Oral capsules Talazoparib
  • Tirana, Albania
  • +1 more
Oct 17, 2021